Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-2-16
pubmed:abstractText
Fluoxetine has been shown to enhance several behavioral effects of cocaine, including its discriminative-stimulus effects. An interaction between increased serotonergic and dopaminergic actions produced by blockade of serotonin and dopamine reuptake, is one possible mechanism for the enhancement. The present study investigated the effects of fluoxetine on the cocaine-like discriminative-stimulus effects of the D(2)-like agonists quinpirole and (-)-NPA, and the D(1)-like agonist SKF 82958 in squirrel monkeys trained to discriminate cocaine. The direct dopaminergic agonists, injected 5 min before testing, produced maximal levels of cocaine-appropriate responding of 50% (0.3 mg/kg, SKF 82958), 67% (0.003 mg/kg, (-)-NPA), and 77% (0.1 mg/kg, quinpirole) with ED(50) values of 0.43, 0.003, and 0.06 mg/kg, respectively. Fluoxetine at doses up to 10 mg/kg (also 5 min before testing) did not alter the effectiveness or the potency of any of the dopamine agonists in substituting for cocaine. The present failure of fluoxetine to alter the cocaine-like discriminative effects of the dopamine agonists is consistent with the notion that the mechanism underlying the enhancement of the effects of cocaine by fluoxetine is not simply an interaction between enhanced serotonergic and dopaminergic activation as it is not obtained with direct-acting dopamine receptor agonists.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-11862342, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-12604093, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-1352052, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-14740149, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-14985417, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-1674533, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-1679852, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-1831559, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-2006243, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-215920, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-2195158, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-2528777, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-7862908, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-7871015, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-7871063, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-7932151, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-8102607, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-9075265, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-9085399, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-9175616, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-9272756, http://linkedlifedata.com/resource/pubmed/commentcorrection/19101584-9495862
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0091-3057
pubmed:author
pubmed:issnType
Print
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
219-23
pubmed:dateRevised
2011-9-29
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Fluoxetine does not alter the ability of dopamine D(1)- and D(2)-like agonists to substitute for cocaine in squirrel monkeys.
pubmed:affiliation
DHHS/NIH/NIDA IRP, Medications Discovery Research Branch, Psychobiology Section, BRC, Room 06A707, 251 Bayview Boulevard, Suite 200, Baltimore, MD 21224, United States. sotop@mail.nih.gov
pubmed:publicationType
Journal Article, Research Support, N.I.H., Intramural